Dimerix hosts US key opinion leader meeting with NephCure Kidney International focused on development path of DMX-200 in kidney disease.
Read the full press release here.
MELBOURNE, Australia, 16th May 2017: Dimerix Limited (ASX: DXB) is on schedule to release final data from its Phase 2 Part A study in Chronic Kidney Disease in July.
Investors are invited to attend a question and answer session with Chief Executive Officer Kathy Harrison. She will provide an overview of […]
Dimerix Limited (ASX:DXB) today announced the appointment of Mr Hugh Alsop as Non-Executive Director.
Read our full announcement here.
Ahead of the clinical trial results to be released mid-year, Dimerix CEO Kathy Harrison will be running shareholder information sessions in most Australian capital cities.
Dates for Perth, Melbourne, Adelaide and Sydney are available here.
These sessions will provide you with an update on the company’s current activities and a briefing on the clinical development […]
To read the announcement and the presentation click here